The sprint to solve coronavirus protein structures — and disarm them with drugs
nature.com · 638 words · saved by 1 readers
Stopping the pandemic could rely on breakneck efforts to visualize SARS-CoV-2 proteins and use them to design drugs and vaccines.
Email Bluesky Facebook LinkedIn Reddit Whatsapp X Credit: Cognition Studio Inc. Access through your institution Buy or subscribe Lying in bed on the night of 10 January, scrolling through news on his smartphone, Andrew Mesecar got an alert. He sat up. It was here. The complete genome of a coronavirus causing a cluster of pneumonia-like cases in Wuhan, China, had just been posted online. Access options Access through your institution Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Learn more Subscribe t
related reading
- Mnemonic portraits for 19,023 human genes — LessWronglesswrong.com
- COVID-19 drug discovery and treatment options | Nature Reviews Microbiologynature.com
- Coronavirus envelope protein - Wikipediaen.wikipedia.org
- Cure all diseasesworksinprogress.news
- AI identifies interactions in CRISPR complexes to improve specificity of DNA editingnature.com
- Unblock research bottlenecks with non-profit start-upsnature.com
- Major AlphaFold upgrade offers boost for drug discoverynature.com
- The trinity of COVID-19: immunity, inflammation and interventionnature.com
- 7 basic science discoveries that changed the worldnature.com
- How antiviral pill molnupiravir shot ahead in the COVID drug huntnature.com
- The speed of science - Works in Progress Magazineworksinprogress.co
- The tangled history of mRNA vaccinesnature.com